Marcia Belvin, SVP, Chief Scientific Officer: CytomX Therapeutics CTMX Sell · Filed 25/06/17

Trade details

Type: Insider sale
Amount: $37,347.96
Shares · price: 13,884 sh · $2.69 a share
Held after: 272,252 sh
Stock: CytomX Therapeutics CTMX
Person: Marcia BelvinSVP, Chief Scientific Officer
Trade date: 25/06/16
Filed: 25/06/17
Days to filing: 1 days

Sold 4.9% of holdings

Share of holding sold: 4.9%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/17~25/07/16

Marcia Belvin's recent trades

Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$202.2K
31,492 sh
$202.2K
Filed 03/19
Traded 03/17
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11.7K
19,512 sh
$11.7K
Filed 25/03/20
Traded 25/03/18
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$26.7K
12,795 sh
$26.7K
Filed 24/03/21
Traded 24/03/19
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20

Marcia Belvin, Chief Officer — sold $37.3K of CytomX Therapeutics CTMX · 4.9% of holdings | Whalegun